Ke Shi,Baiyun Jia,Yuanyu Li,Xiaojuan Feng,Xusheng Sun,Qingjuan Liu,Wei Zhang,Yuexin Tian,Xinyan Miao,Yunhe Liu,Hang Zhao,Lihua Kang,Tongyu Zhao,Shiqi Zhang,Jinxi Liu,Shuxia Liu
{"title":"TRIM44的缺失通过调节k48相关的vimentin泛素化促进肾细胞癌的进展。","authors":"Ke Shi,Baiyun Jia,Yuanyu Li,Xiaojuan Feng,Xusheng Sun,Qingjuan Liu,Wei Zhang,Yuexin Tian,Xinyan Miao,Yunhe Liu,Hang Zhao,Lihua Kang,Tongyu Zhao,Shiqi Zhang,Jinxi Liu,Shuxia Liu","doi":"10.1016/j.jbc.2025.110734","DOIUrl":null,"url":null,"abstract":"Tripartite motif-containing 44 (TRIM44), a member of the TRIM protein family, has emerged as a regulator in multiple cancer types, yet its functional role and molecular mechanisms in clear cell renal cell carcinoma (ccRCC) remain poorly characterized. Here, we identified TRIM44 as a tumor suppressor in ccRCC through integrated clinical and functional analyses. Clinically, TRIM44 expression was significantly downregulated in ccRCC tissues compared with adjacent normal tissues, and its reduced expression correlated with advanced tumor stage and poor patient prognosis. Functionally, gain- and loss-of-function experiments demonstrated that TRIM44 potently inhibited ccRCC cell migration, invasion, and proliferation in vitro and in vivo. Mechanistically, TRIM44 directly interacts with vimentin. Importantly, we found that TRIM44 promotes K48-linked polyubiquitination of vimentin through its B-box domain, thereby targeting vimentin for proteasomal degradation. Collectively, our study establishes TRIM44 as a critical regulator of ccRCC progression through vimentin destabilization, highlighting its potential as both a prognostic biomarker and therapeutic target for ccRCC.","PeriodicalId":15140,"journal":{"name":"Journal of Biological Chemistry","volume":"68 1","pages":"110734"},"PeriodicalIF":4.0000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Loss of TRIM44 promotes renal cell carcinoma progression by regulating K48-linked ubiquitination of vimentin.\",\"authors\":\"Ke Shi,Baiyun Jia,Yuanyu Li,Xiaojuan Feng,Xusheng Sun,Qingjuan Liu,Wei Zhang,Yuexin Tian,Xinyan Miao,Yunhe Liu,Hang Zhao,Lihua Kang,Tongyu Zhao,Shiqi Zhang,Jinxi Liu,Shuxia Liu\",\"doi\":\"10.1016/j.jbc.2025.110734\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Tripartite motif-containing 44 (TRIM44), a member of the TRIM protein family, has emerged as a regulator in multiple cancer types, yet its functional role and molecular mechanisms in clear cell renal cell carcinoma (ccRCC) remain poorly characterized. Here, we identified TRIM44 as a tumor suppressor in ccRCC through integrated clinical and functional analyses. Clinically, TRIM44 expression was significantly downregulated in ccRCC tissues compared with adjacent normal tissues, and its reduced expression correlated with advanced tumor stage and poor patient prognosis. Functionally, gain- and loss-of-function experiments demonstrated that TRIM44 potently inhibited ccRCC cell migration, invasion, and proliferation in vitro and in vivo. Mechanistically, TRIM44 directly interacts with vimentin. Importantly, we found that TRIM44 promotes K48-linked polyubiquitination of vimentin through its B-box domain, thereby targeting vimentin for proteasomal degradation. Collectively, our study establishes TRIM44 as a critical regulator of ccRCC progression through vimentin destabilization, highlighting its potential as both a prognostic biomarker and therapeutic target for ccRCC.\",\"PeriodicalId\":15140,\"journal\":{\"name\":\"Journal of Biological Chemistry\",\"volume\":\"68 1\",\"pages\":\"110734\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-09-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Biological Chemistry\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jbc.2025.110734\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Biological Chemistry","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.jbc.2025.110734","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Loss of TRIM44 promotes renal cell carcinoma progression by regulating K48-linked ubiquitination of vimentin.
Tripartite motif-containing 44 (TRIM44), a member of the TRIM protein family, has emerged as a regulator in multiple cancer types, yet its functional role and molecular mechanisms in clear cell renal cell carcinoma (ccRCC) remain poorly characterized. Here, we identified TRIM44 as a tumor suppressor in ccRCC through integrated clinical and functional analyses. Clinically, TRIM44 expression was significantly downregulated in ccRCC tissues compared with adjacent normal tissues, and its reduced expression correlated with advanced tumor stage and poor patient prognosis. Functionally, gain- and loss-of-function experiments demonstrated that TRIM44 potently inhibited ccRCC cell migration, invasion, and proliferation in vitro and in vivo. Mechanistically, TRIM44 directly interacts with vimentin. Importantly, we found that TRIM44 promotes K48-linked polyubiquitination of vimentin through its B-box domain, thereby targeting vimentin for proteasomal degradation. Collectively, our study establishes TRIM44 as a critical regulator of ccRCC progression through vimentin destabilization, highlighting its potential as both a prognostic biomarker and therapeutic target for ccRCC.
期刊介绍:
The Journal of Biological Chemistry welcomes high-quality science that seeks to elucidate the molecular and cellular basis of biological processes. Papers published in JBC can therefore fall under the umbrellas of not only biological chemistry, chemical biology, or biochemistry, but also allied disciplines such as biophysics, systems biology, RNA biology, immunology, microbiology, neurobiology, epigenetics, computational biology, ’omics, and many more. The outcome of our focus on papers that contribute novel and important mechanistic insights, rather than on a particular topic area, is that JBC is truly a melting pot for scientists across disciplines. In addition, JBC welcomes papers that describe methods that will help scientists push their biochemical inquiries forward and resources that will be of use to the research community.